|  | Surgery & Procedures | Gastric Band Surgery

SAG LTO Ultrasound-Guided Lung Biopsy: Technique & Indications

SAG LTO = Single Access, Single Gauge, Lung Target Only — a streamlined percutaneous lung biopsy technique using a single coaxial needle system under real-time ultrasound guidance.

Technique Overview

  1. Patient positioning: Optimized for target access (supine, decubitus, prone)
  2. Ultrasound window identification: Pleural-based or parenchymal lesion abutting pleura (no aerated lung interposition)
  3. Single puncture: Coaxial introducer needle (typically 17-19G) advanced to pleural surface
  4. Core biopsy: Automated biopsy gun (18-20G) through introducer — multiple passes
  5. Optional: Aspiration for cytology/microbiology through same tract
  6. Tract ablation (optional): Cautery or gel foam on withdrawal if bleeding risk

Key Advantages

  • Single pleural puncture: Reduces pneumothorax risk vs. multi-pass techniques
  • Real-time visualization: Needle tip and lesion throughout
  • No ionizing radiation (vs. CT-guided)
  • Bedside/portable: ICU, OR, interventional suite
  • Cost-effective: Less equipment, shorter procedure time

Patient Selection Criteria

  • Lesion ≥1 cm, abutting pleura (no aerated lung between probe and target)
  • Coagulopathy corrected (INR ≤1.5, platelets ≥50K)
  • No contralateral pneumonectomy
  • Cooperative (breath-hold capability) or ventilated with controlled apnea

Limitations

  • Cannot reach central/mediastinal lesions without pleural contact
  • Subpleural lesions <1 cm technically challenging
  • Operator-dependent (ultrasound skill + biopsy technique)
  • Not suitable for fiducial placement or ablation (different tools)

Diagnostic Yield & Complications

  • Diagnostic yield: 85-95% for malignant lesions (comparable to CT-guided)
  • Pneumothorax: 10-25% (chest tube required: 2-5%)
  • Hemoptysis: 5-10% (usually self-limited)
  • Air embolism: Rare (<0.1%)

Post-Procedure

  • 2-4 hour observation, repeat CXR at 2-4 hours
  • Discharge if stable; admit if pneumothorax >20% or symptomatic
  • Results: 2-5 business days (core histology ± molecular)

SAG LTO expands biopsy access for pleural-based lesions, especially in settings without CT fluoroscopy or for patients who cannot tolerate CT positioning.

Gastric Band Surgery - Related Articles